Can we improve fixation and outcomes in the treatment of femoral neck fractures? The use of pharmaceuticals

Journal of Orthopaedic Trauma

Volumn 23, Issue 6, 2009, Pages 413-421

  Kakar, Sanjeev ^a   Little, David ^b   Einhorn, Thomas A ^a  

^a BOSTON UNIVERSITY MEDICAL CENTER   (United States)

^b CHILDREN S HOSPITAL AT WESTMEAD   (Australia)

Author keywords

Bisphosphonates; Hip fractures; Parathyroid hormone

Indexed keywords

ALENDRONIC ACID; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; CLODRONIC ACID; DENOSUMAB; ETIDRONIC ACID; IBANDRONIC ACID; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INCADRONIC ACID; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; PAMIDRONIC ACID; PARATHYROID HORMONE; PARATHYROID HORMONE[1-34]; PLACEBO; RECOMBINANT PARATHYROID HORMONE; RISEDRONIC ACID; TILUDRONIC ACID; VITAMIN D; ZOLEDRONIC ACID;

AVASCULAR NECROSIS; BIOMECHANICS; BONE DENSITY; BONE METASTASIS; BONE MINERAL; BONE NECROSIS; BONE PAIN; BONE SCREW; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; CALLUS; CONFERENCE PAPER; DIET SUPPLEMENTATION; DRUG APPROVAL; DRUG INDICATION; DRUG INTERMITTENT THERAPY; DRUG WITHDRAWAL; ENDOPROSTHESIS LOOSENING; FEMUR NECK FRACTURE; FEVER; FRACTURE FIXATION; FRACTURE HEALING; FRACTURE NONUNION; FRACTURE TREATMENT; HIP ARTHROPLASTY; HIP FRACTURE; HIP RADIOGRAPHY; HORMONE ACTION; HUMAN; HYPERCALCEMIA; IMPLANT; JAW OSTEONECROSIS; MICRO-COMPUTED TOMOGRAPHY; MYALGIA; NONHUMAN; OPEN REDUCTION; OSTEOPOROSIS; OSTEOSYNTHESIS; PAGET BONE DISEASE; POSTMENOPAUSE OSTEOPOROSIS; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; REPEATED DRUG DOSE; RISK REDUCTION; SINGLE DRUG DOSE; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; TREATMENT OUTCOME; VERTEBRA FRACTURE; WRIST FRACTURE;

ANABOLIC AGENTS; COMBINED MODALITY THERAPY; EVIDENCE-BASED MEDICINE; FEMORAL NECK FRACTURES; FRACTURE FIXATION, INTERNAL; HUMANS;

EID: 67651024740     PISSN: 08905339     EISSN: None     Source Type: Journal    
DOI: 10.1097/BOT.0b013e3181ac64a0     Document Type: Conference Paper

References (84)

1. Cummings SR, Rubin SM, Black D. The future of hip fractures in the United States. Numbers, costs, and potential effects of postmenopausal estrogen. Clin Orthop Relat Res. 1990;252:163-166.
2. Cooper C, Campion G, Melton LJ. Hip fractures in the elderly: a worldwide projection. Osteoporos Int. 1992;2:6:285-289.
3. Barnes JT, Brown JT, Garden RS, et al. Subcapital fractures of the femur: a retrospective review. J Bone Joint Surg Br. 1976;58:2-24.
4. Dorne HE, Lander PH. Spontaneous stress fractures of the femoral neck. Am J Radiol. 1995;144:343.
5. Augat P, Fan B, Lane NE, et al. Assessment of bone mineral at appendicular sites in females with fractures of the proximal femur. Bone. 1998;22:395-402. (Pubitemid 28177194)
6. Aitken JM. Relevance of osteoporosis in women with fracture of the femoral neck. Br Med J (Clin Res Ed). 1984;288:597-601. (Pubitemid 14081394)
7. Singh M, Nagrath AR, Maini PS. Changes in trabecular pattern of the upper end of the femur as an index of osteoporosis. J Bone Joint Surg Am. 1970;52:457-467.
8. Arnold WD. The effect of early weight-bearing on the stability of femoral neck fractures treated with Knowles pins. J Bone Joint Surg Am. 1984;66:847-852.
9. National Osteoporosis Foundation Guidelines 2007. Available at: http:// www.nof.org/professionals/powerpointpresentation/index.htm.
10. Laursen JO. Treatment of intracapsular fractures of the femoral neck in Denmark: trends over the past decade. Acta Orthop Belg. 1999;65:478-484.
11. Chua D, Jaglal SB, Schatzker J. An orthopedic surgeon survey on the treatment of displaced femoral neck fracture: opposing views. Can J Surg. 1997;40:271-277. (Pubitemid 27374765)
12. Parker MJ, Pryor G. Internal fixation or arthroplasty for displaced cervical hip fractures in the elderly. Acta Orthop Scand. 2000;71:440-445.
13. Parker MJ, Pryor GA. Internal fixation or arthroplasty for displaced cervical hip fractures in the elderly: a randomised controlled trial of 208 patients. Acta Orthop Scand. 2000;71:440-446.
14. Ravikumar KJ, Marsh G. Internal fixation versus hemiarthroplasty versus total hip arthroplasty for displaced subcapital fractures of femur - 13 year results of a prospective randomised study. Injury. 2000;31:793-797. (Pubitemid 32012474)
15. Johansson T, Jacobsson SA, et al. Ivarsson I, et al. Internal fixation versus total hip arthroplasty in the treatment of displaced femoral neck fractures: a prospective randomized study of 100 hips. Acta Orthop Scand. 2000;71:597-602.
16. Lowell JD. Results and complications of femoral neck fractures. Clin Orthop. 1980;152:162-172. (Pubitemid 11199826)
17. Frangakis EK. Intracapsular fractures of the neck of the femur. Factors influencing nonunion and ischaemic necrosis. J Bone Joint Surg Br. 1966;48:17-30.
18. Garden RS. Reduction and fixation of subcapital fractures of the femur. Orthop Clin North Am. 1974;5:683-712.
19. Kyle RF, Wright TM, Burstein AH. Biomechanical analysis of the sliding characteristics of compression hip screws. J Bone Joint Surg Am. 1980;62:1308-1314.
20. Di Muria GV, Marcucci M, Pitto RP, et al. Verified causes of failure in the treatment of femoral neck fractures with multiple Knowles pins. Ital J Orthop Traumatol. 1991;17:107-116.
21. Estrada LS, Volgas DA, Stannard JP, et al. Fixation failure in femoral neck fractures. Clin Orthop. 2002;399:110-118. (Pubitemid 34596103)
22. Banks HH. Factors influencing the result in fractures of the femoral neck. J Bone Joint Surg Am. 1962;44:931-964.
23. Banks HH. Nonunion in fractures of the femoral neck. Orthop Clin North Am. 1974;5:865-885.
24. Alberts KA, Jervaeus J. Factors predisposing to healing complications after internal fixation of femoral neck fracture. A stepwise logistic regression analysis. Clin Orthop Relat Res. 1990;257:129-133.
25. Krischak G, Beck A,Wachter N, et al. Relevance of primary reduction for the clinical outcome of femoral neck fractures treated with cancellous screws. Arch Orthop Trauma Surg. 2003;123:404-409.
26. Sochart DH. Poor results following internal fixation of displaced subcapital femoral fractures: complacency in fracture reduction. Arch Orthop Trauma Surg. 1998;117:379-382.
27. Asnis SE, Wanek-Sgaglione L. Intracapsular fractures of the femoral neck: results of cannulated screw fixation. J Bone Joint Surg Am. 1994;76:1793-1803.
28. Bray TJ. Femoral neck fracture fixation. Clin Orthop. 1997;339:20-31.
29. Alho A, Benterud JG, Muller C, et al. Prediction of fixation failure in femoral neck fractures. Comminution and avascularity studied in 40 patients. Acta Orthop Scand. 1993;64:408-410.
30. Kauffman JI, Simon JA, Kummer FJ, et al. Internal fixation of femoral neck fractures with posterior comminution: a biomechanical study. J Orthop Trauma. 1999;13:155-159.
31. Lindequist S, Tornkvist H. Quality of reduction and cortical screw support in femoral neck fractures. An analysis of 72 fractures with a new computerized measuring method. J Orthop Trauma. 1995;9:215-221.
32. Gurusamy K, Parker MJ, Rowlands TK. The complications of displaced intracapsular fractures of the hip: the effect of screw positioning and angulation on fracture healing. J Bone Joint Surg Br. 2005;87:632-634. (Pubitemid 40711634)
33. Bonnaire FA, Weber AT. Analysis of fracture gap changes, dynamic and static stability of different osteosynthetic procedures in the femoral neck. Injury. 2002;33(Suppl 3):C24-C32.
34. Sjostedt A, Zetterberg C, Hansson T, et al. Bone mineral content and fixation strength of femoral neck fractures: a cadaver study. Acta Orthop Scand. 1994;65:161-165. (Pubitemid 24153941)
35. Levi N, Ingles A Jr, Klyver H, et al. Fracture of the femoral neck: optimal screw position and bone density determined by computer tomography. Injury. 1996;27:287-289. (Pubitemid 26154196)
36. Stromsoe K, Kok WL, Hoiseth A, et al. Holding power of the 4.5 mm AO/ ASIF cortex screw in cortical bone in relation to bone mineral. Injury. 1993;24:656-659. (Pubitemid 24002856)
37. Alho A, Benterud JG, Solovieva S. Internally fixed femoral neck fractures. Early prediction of failure in 203 elderly patients with displaced fractures. Acta Orthop Scand. 1999;70:141-144.
38. Barrios C, Bostrom LA, Stark A. Healing complications after internal fixation of trochanteric hip fractures: the prognostic value of osteoporosis. J Orthop Trauma. 1993;7:438-442.
39. Hedstrom M. Are patients with a nonunion after a femoral neck fracture more osteoporotic than others? BMD measurement before the choice of treatment? A pilot study of hip BMD and biochemical bone markers in patients with femoral neck fractures. Acta Orthop Scand. 2004;75: 50-52. (Pubitemid 38264924)
40. Kyle RF, Cabanela ME, Russell TA. Fractures of the proximal part of the femur. Instr Course Lect. 1995;44:227-253.
41. Catto M. A histological study of avascular necrosis of the femoral head after transcervical fracture. J Bone Joint Surg Br. 1965;47:749-776.
42. Garden RS. The significance of good reduction in medial fractures of the femoral neck. Proc R Soc Med. 1970;63:1122.
43. Garden RS. Malreduction and avascular necrosis in subcapital fractures of the femur. J Bone Joint Surg Br. 1971;53:183-196.
44. Sevitt S, Thompson RG. The distribution and anastomoses of arteries supplying the head and neck of the femur. J Bone Joint Surg Br. 1965;47: 560-573.
45. Moore AT. Hip joint fracture (a mechanical problem). Instr Course Lect. 1953;10:35-49.
46. Bonnaire F, Schaefer DJ, Kuner EH. Hemarthrosis and hip joint pressure in femoral neck fractures. Clin Orthop Relat Res. 1998;353:148-155. (Pubitemid 28385456)
47. Moon MS, Cho DY. Trochanteric intra-osseous venography in femoral neck fractures in the dog. Int Orthop. 1980;3:265-269.
48. Cho TJ, Gerstenfeld LC, Einhorn TA. Differential temporal expression of members of the transforming growth factor b superfamily during murine fracture healing. J Bone Miner Res. 2002;17:513.
49. Juppner H, Kronenberg HM. Parathyroid hormone (chapter 18). In: Favus MJ, ed. Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism. 5th ed. Washington DC: Association of Bone and Mineral Research; 2003:117-124.
50. Podbesek R, Edouard C, Meunier PJ, et al. Effects of two treatment regimes with synthetic human parathyroid hormone fragment on bone formation and the tissue balance of trabecular bone in greyhounds. Endocrinology. 1983;112:1000-1006.
51. Hock JM, Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res. 1992;7:65-72.
52. Neer RM, Arnaud CD, Zanchetta JR, et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med. 2001;344:1434-1441.
53. Black DM, Greenspan SL, Ensrud KE, et al. The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. N Engl J Med. 2003;349:1207-1215. (Pubitemid 37152030)
54. Black DM, Bilezikian JP, Ensrud KE, et al. One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. N Engl J Med. 2005;353:555-565.
55. Andreassen TT, Ejersted C, Oxlund H. Intermittent parathyroid hormone (1-34) treatment increases callus formation and mechanical strength of healing rat fractures. J Bone Miner Res. 1999;14:960-968.
56. Andreassen TT, Fledelius C, Ejersted C, et al. Increases in callus formation and mechanical strength of healing fractures in old rats treated with parathyroid hormone. Acta Orthop Scand. 2001;72:304-307 (Pubitemid 32613496)
57. Alkhiary YM, Gerstenfeld LC, Krall E, et al. Enhancement of experimental fracture-healing by systemic administration of recombinant human parathyroid hormone (PTH 1-34). J Bone Joint Surg Am. 2005;87:731-741. (Pubitemid 40489347)
58. Nakajima A, Shimoji N, Shiomi K, et al. Mechanisms for the enhancement of fracture healing in rats treated with intermittent low-dose human parathyroid hormone (1-34). J Bone Miner Res. 2002;17:2038-2047. (Pubitemid 35239205)
59. Ejersted C, Andreassen TT, Oxlund H, et al. Human parathyroid hormone (1-34) and (1-84) increase the mechanical strength and thickness of cortical bone in rats. J Bone Miner Res. 1993;8:1097-1101. (Pubitemid 23261103)
60. Ejersted C, Andreassen TT, Hauge EM, et al. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength and quality in old rats. Bone. 1995;17:507-511.
61. Skripitz R, Aspenberg P. Early effect of parathyroid hormone (1-34) on implant fixation. Clin Orthop Relat Res. 2001;392:427-432.
62. Skripitz R, Aspenberg P. Implant fixation enhanced by intermittent treatment with parathyroid hormone. J Bone Joint Surg Br. 2001;83:437-440. (Pubitemid 32390361)
63. Skripitz P, Bohling S, Ruther W, et al. Stimulation of implant fixation by parathyroid hormone (1-34) - a histomorphometric comparison of PMMA cement and stainless steel. J Orthop Res. 2005;23:1266-1270.
64. Hilding M, Ryd L, Toksvig-Larsen S, et al. Clodronate prevents prosthetic migration. A randomized radiostereometric study of 50 total knee patients. Acta Orthop Scand. 2000;71:553-557.
65. Skripitz R, Aspenberg P. Parathyroid hormone - a drug for orthopaedic surgery? Acta Orthop Scand. 2004;75:654-662.
66. Fleisch H. Bisphosphonates: mechanisms of action. Endocr Rev. 1998;19:80-100.
67. Fleisch H. Bisphosphonates. Pharmacology and use in the treatment of tumour-induced hypercalcaemic and metastatic bone disease. Drugs. 1991;42:919-944.
68. Russell RG, Rogers MJ. Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999;25:97-106.
69. Black DM, Cummings SR, Karpf DB, et al. Randomized trial effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group. Lancet. 1996;348:1535-1541.
70. Lyles KW, Colon-Emeric CS, Magaziner JS, et al. Zoledronic acid and clinical features and mortality after hip fracture. N Engl J Med. 2007;357:1799-1809.
71. Morris CD, Einhorn TA. Bisphosphonates in orthopaedic surgery. J Bone Joint Surg Am. 2005;87:1609-1618.
72. Luckman SP, Hughes DE, Coxon FP, et al. Nitrogen containing bisphosphonates inhibit the mevalonate pathway and prevent posttranslational prenylation of GTP binding proteins, including Ras. J Bone Miner Res. 1998;13:581-589.
73. Fisher JE, Rogers MJ, Halasy JM, et al. Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci U S A. 1999;96:133-138.
74. Goodship AE, Walker PC, McNally D, et al. Use of a bisphosphonate (pamidronate) to modulate fracture repair in ovine bone. Ann Oncol. 1994; (5 suppl 7):S53-S55. (Pubitemid 24382836)
75. Peter CP, Cook WO, Nunamaker DM, et al. Effect of alendronate on fracture healing and bone remodeling in dogs. J Orthop Res. 1996;14:74-79.
76. Li C, Mori S, Li J, et al. Long-term effect of incadronate disodium (YM-175) on fracture healing of femoral shaft in growing rats. J Bone Miner Res. 2001;16:429-436. (Pubitemid 32173356)
77. Amanat N, Brown R, Bilston LE, et al. A single systemic dose of pamidronate improves bone mineral content and accelerates restoration of strength in a rat model of fracture repair. J Orthop Res. 2005;23:1029-1034. (Pubitemid 41245425)
78. Skoglund B, Holmertz J, Aspenberg P. Systemic and local ibandronate enhance screw fixation. J Orthop Res. 2004;22:1108-1113. (Pubitemid 39145130)
79. Tanzer M, Karabasz D, Krygier JJ, et al. The Otto Aufranc Award: bone augmentation around and within porous implants by local bisphosphonate elution. Clin Orthop Relat Res. 2005;441:30-39. (Pubitemid 44384201)
80. Woo SB, Hellstein JW, Kalmar JR. Systematic review: bisphosphonates and osteonecrosis of the jaws. Ann Intern Med. 2006;144:753-761. (Pubitemid 46780635)
81. Gasser JA. The relative merits of anabolics versus anti-resorptive compounds: where our targets should be, and whether we are addressing them. Curr Opin Pharmacol. 2006;6:313-318.
82. McClung MR, Lewiecki EM, Cohen SB, et al. Denosumab in postmenopausal women with low bone mineral density. N Engl J Med. 2006;354:821-831. (Pubitemid 43290920)
83. Flick LM, Weaver JM, Ulrich-Vinther M, et al. Effects of receptor activator of NFkappaB (RANK) signaling blockade on fracture healing. J Orthop Res. 2003;21:676-684. (Pubitemid 36758211)
84. Ulrich-Vinther M, Andreassen TT. Osteoprotegerin treatment impairs remodeling and apparent material properties of callus tissue without influencing structural fracture strength. Calcif Tissue Int. 2005;76:280-286. (Pubitemid 40991399)